Risk Stratification for Patients With Hospital-diagnosed Advanced Lung Cancer
This study explores whether supportive care interventions that might reduce rehospitalization could be implemented and feasible, in subjects within a high-risk group of subjects with newly diagnosed hospitalized advanced lung cancer (ALC). This study screened 50 subjects from health records and consented to 15 of these screened subjects. These 15 subjects responded to PRO questionnaires.
Checked against the public recordLast updated May 25, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria for Patient Participants: 1. Age ≥ 18 years at the time of screening. 2. Hospital-diagnosed Advanced lung cancer with histological confirmation of disease or suspected lung cancer in the opinion of the treating oncologist. For PROs only 1\. Able to complete a web-based or telephonic symptom survey. Exclusion Criteria for Patient Participants: 1\. Enrollment in hospice upon discharge from the index hospitalization For PROs only 1. Inability to read or speak English. 2. Dementia, altered mental status, or any psychiatric condition as determined by the clinical or study team that would prohibit the understanding or rendering of informed consent. 3. Current incarceration. 4. Any condition that would prohibit the patient from completing PROs Inclusion Criteria for Health Care Provider Participants: 1\. Thoracic medical oncology physicians, advance practice providers, and nurse navigators work in the study site and respond to the survey that assesses acceptability.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- UNC LinebergerChapel Hill, North Carolina
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 25, 2025. Always confirm current availability with the study team.